Mission Wealth Management, LP Novo Nordisk A S Transaction History

Mission Wealth Management, LP

  • $4.1 Billion
  • Q3 2024

A detailed history of Mission Wealth Management, LP transactions in Novo Nordisk A S stock. As of the latest transaction made, Mission Wealth Management, LP holds 26,835 shares of NVO stock, worth $2.9 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
26,835
Previous 23,939 12.1%
Holding current value
$2.9 Million
Previous $3.42 Million 6.5%
% of portfolio
0.08%
Previous 0.09%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024
BUY
$119.07 - $145.42 $344,826 - $421,136
2,896 Added 12.1%
26,835 $3.2 Million
Q2 2024

Aug 02, 2024
BUY
$122.71 - $146.91 $78,288 - $93,728
638 Added 2.74%
23,939 $3.42 Million
Q1 2024

Apr 30, 2024
BUY
$102.11 - $135.92 $117,222 - $156,036
1,148 Added 5.18%
23,301 $2.99 Million
Q4 2023

Feb 05, 2024
BUY
$87.78 - $105.45 $132,460 - $159,124
1,509 Added 7.31%
22,153 $2.29 Million
Q3 2023

Oct 23, 2023
BUY
$90.94 - $199.54 $928,406 - $2.04 Million
10,209 Added 97.83%
20,644 $1.88 Million
Q2 2023

Aug 04, 2023
SELL
$155.98 - $172.65 $54,437 - $60,254
-349 Reduced 3.24%
10,435 $1.69 Million
Q1 2023

Apr 07, 2023
SELL
$132.34 - $159.14 $46,583 - $56,017
-352 Reduced 3.16%
10,784 $1.72 Million
Q4 2022

Feb 02, 2023
SELL
$102.55 - $135.33 $2,256 - $2,977
-22 Reduced 0.2%
11,136 $1.51 Million
Q3 2022

Oct 12, 2022
BUY
$95.28 - $116.93 $25,153 - $30,869
264 Added 2.42%
11,158 $1.11 Million
Q2 2022

Jul 27, 2022
BUY
$103.24 - $121.81 $137,618 - $162,372
1,333 Added 13.94%
10,894 $1.21 Million
Q1 2022

Apr 25, 2022
BUY
$93.1 - $112.54 $40,126 - $48,504
431 Added 4.72%
9,561 $1.06 Million
Q4 2021

Feb 11, 2022
BUY
$95.88 - $117.08 $131,835 - $160,985
1,375 Added 17.73%
9,130 $1.02 Million
Q3 2021

Nov 05, 2021
BUY
$84.42 - $106.62 $675 - $852
8 Added 0.1%
7,755 $745,000
Q2 2021

Aug 10, 2021
SELL
$67.66 - $84.76 $6,157 - $7,713
-91 Reduced 1.16%
7,747 $649,000
Q1 2021

May 10, 2021
BUY
$67.06 - $75.82 $117,489 - $132,836
1,752 Added 28.79%
7,838 $528,000
Q4 2020

Jan 19, 2021
BUY
$63.89 - $73.8 $135,063 - $156,013
2,114 Added 53.22%
6,086 $425,000
Q3 2020

Oct 16, 2020
BUY
$63.69 - $70.22 $26,940 - $29,703
423 Added 11.92%
3,972 $276,000
Q2 2020

Aug 03, 2020
BUY
$58.54 - $67.94 $3,863 - $4,484
66 Added 1.89%
3,549 $232,000
Q4 2019

Jan 21, 2020
SELL
$49.86 - $58.26 $20,891 - $24,410
-419 Reduced 10.74%
3,483 $202,000
Q3 2019

Oct 16, 2019
BUY
$47.54 - $53.43 $185,501 - $208,483
3,902 New
3,902 $202,000
Q2 2019

Aug 09, 2019
SELL
$46.79 - $52.47 $183,978 - $206,312
-3,932 Closed
0 $0
Q1 2019

May 14, 2019
BUY
$46.36 - $52.63 $182,287 - $206,941
3,932 New
3,932 $206,000

Others Institutions Holding NVO

# of Institutions
1,956
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Mission Wealth Management, LP Portfolio

Follow Mission Wealth Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mission Wealth Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Mission Wealth Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email